These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24495352)

  • 21. Regulation of Sox6 by cyclin dependent kinase 5 in brain.
    Rudrabhatla P; Utreras E; Jaffe H; Kulkarni AB
    PLoS One; 2014; 9(3):e89310. PubMed ID: 24662752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
    Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature.
    Alhowail A; Alsikhan R; Alsaud M; Aldubayan M; Rabbani SI
    Drug Des Devel Ther; 2022; 16():2919-2931. PubMed ID: 36068789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARγ activation ameliorates postoperative cognitive decline probably through suppressing hippocampal neuroinflammation in aged mice.
    Zhang Z; Yuan H; Zhao H; Qi B; Li F; An L
    Int Immunopharmacol; 2017 Feb; 43():53-61. PubMed ID: 27940378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosiglitazone, PPARγ, and type 2 diabetes.
    Kahn BB; McGraw TE
    N Engl J Med; 2010 Dec; 363(27):2667-9. PubMed ID: 21190462
    [No Abstract]   [Full Text] [Related]  

  • 27. Cdk5/p35 functions as a crucial regulator of spatial learning and memory.
    Mishiba T; Tanaka M; Mita N; He X; Sasamoto K; Itohara S; Ohshima T
    Mol Brain; 2014 Nov; 7():82. PubMed ID: 25404232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPARγ-mediated microglial activation phenotype is involved in depressive-like behaviors and neuroinflammation in stressed C57BL/6J and ob/ob mice.
    Qin X; Wang W; Wu H; Liu D; Wang R; Xu J; Jiang H; Pan F
    Psychoneuroendocrinology; 2020 Jul; 117():104674. PubMed ID: 32422516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes.
    Rai A; Tripathi S; Kushwaha R; Singh P; Srivastava P; Sanyal S; Bandyopadhyay S
    Cell Death Dis; 2014 Jan; 5(1):e1033. PubMed ID: 24481447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
    Quan Q; Qian Y; Li X; Li M
    J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation.
    Biscetti F; Straface G; Arena V; Stigliano E; Pecorini G; Rizzo P; De Angelis G; Iuliano L; Ghirlanda G; Flex A
    Cardiovasc Diabetol; 2009 Sep; 8():49. PubMed ID: 19737384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
    Choi JH; Banks AS; Estall JL; Kajimura S; Boström P; Laznik D; Ruas JL; Chalmers MJ; Kamenecka TM; Blüher M; Griffin PR; Spiegelman BM
    Nature; 2010 Jul; 466(7305):451-6. PubMed ID: 20651683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins.
    Kanungo J; Zheng YL; Amin ND; Pant HC
    J Neurochem; 2008 Sep; 106(5):2236-48. PubMed ID: 18662245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
    Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.
    Nicolakakis N; Aboulkassim T; Ongali B; Lecrux C; Fernandes P; Rosa-Neto P; Tong XK; Hamel E
    J Neurosci; 2008 Sep; 28(37):9287-96. PubMed ID: 18784309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forebrain glutamatergic neuron-specific Ctcf deletion induces reactive microgliosis and astrogliosis with neuronal loss in adult mouse hippocampus.
    Kwak JH; Lee K
    BMB Rep; 2021 Jun; 54(6):317-322. PubMed ID: 33612151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin-Dependent Kinase 5 Regulates Dendritic Spine Formation and Maintenance of Cortical Neuron in the Mouse Brain.
    Mita N; He X; Sasamoto K; Mishiba T; Ohshima T
    Cereb Cortex; 2016 Mar; 26(3):967-976. PubMed ID: 25404468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.